• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United State

tetano

Editor, Senior Moderator
Vaccine


. 2021 Jun 23;S0264-410X(21)00798-2.
doi: 10.1016/j.vaccine.2021.06.048. Online ahead of print.
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia


Mallory Trent[SUP] 1 [/SUP], Holly Seale[SUP] 2 [/SUP], Abrar Ahmad Chughtai[SUP] 3 [/SUP], Daniel Salmon[SUP] 4 [/SUP], C Raina MacIntyre[SUP] 5 [/SUP]



Affiliations

Abstract

Background: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia.
Objective: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia.
Design: Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020.
Participants, setting: Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix.
Main outcomes and measures: Willingness to receive a COVID-19 vaccine; reason for vaccine intention.
Statistical methods: To identify predictors of intention to receive a COVID-19 vaccine, we used Poisson regression with robust error estimation to produce prevalence ratios.
Results: The proportion willing to receive a COVID-19 vaccine was 70% in London, 71% NYC, 72% in Sydney, 76% in Phoenix, and 78% in Melbourne. Age was the only sociodemographic characteristic that predicted willingness to receive a COVID-19 vaccine in all five cities. In Sydney and Melbourne, participants with high confidence in their current government had greater willingness to receive the vaccine (PR = 1.24; 95% CI = 1.07-1.44 and PR = 1.38; 95% CI = 1.74-1.62), while participants with high confidence in their current government in NYC and Phoenix were less likely to be willing to receive the vaccine (PR = 0.78; 95% CI = 0.72-0.85 and PR = 0.85; 95% CI = 0.76-0.96).
Limitations: Consumer panels can be subject to bias and may not be representative of the general population.
Conclusions: Success for COVID-19 vaccination programs requires high levels of vaccine acceptance. Our data suggests more than 25% of adults may not be willing to receive a COVID-19 vaccine, but many of them were not explicitly anti-vaccination and thus may become more willing to vaccinate over time. Among the three countries surveyed, there appears to be cultural differences, political influences, and differing experiences with COVID-19 that may affect willingness to receive a COVID-19 vaccine.

Keywords: COVID-19; Coronavirus; SARS-CoV-2; Vaccine hesitancy.
 
Back
Top Bottom